欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Immunology/Inflammation > YQ128

浏览历史

S89289

YQ128

源叶(MedMol) 98%
  • 英文名:
  • YQ128
  • 别名:
  • CAS号:
  • 2454246-18-3
  • 分子式:
  • C₂₇H₂₉ClN₂O₄S₂
  • 分子量:
  • 545.11
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S89289-5mg 98% ¥830.00元 6 - - - EA 加入购物车
源叶(MedMol) S89289-10mg 98% ¥1380.00元 7 - - - EA 加入购物车
源叶(MedMol) S89289-25mg 98% ¥2770.00元 6 - - - EA 加入购物车
源叶(MedMol) S89289-100mg 98% ¥6200.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: YQ128 is a potent and selective second-generation NLRP3 (NOD-like receptor P3) inflammasome inhibitor with an IC50 of 0.30 µM. YQ128 significantly and selectively suppresses the production of IL-1β, but not TNF-α, and it can cross the BBB to reach the CNS. YQ128 has anti-inflammatory activity
  • 靶点: NLRP3:0.30 μM (IC50);IL-1β;ILReceptor; NOD-likeReceptor(NLR); NOD; Interleukin
  • 体外研究:
    YQ128 (0.3-100 µM; 30 mins) dose dependently suppressed the release of IL-1β from peritoneal macrophages upon LPS/ATP challenge with an IC50 of 1.59 µM. YQ128 (20 µM; 2 hours) shows no significant toxic effects on hCMEC/D3 cells. Cell Viability Assay Cell Line: Mouse peritoneal macrophages Concentration: 0.3, 1.0, 3.0, 10, 30, 100 µM Incubation Time: 30 mins Result: Suppressed the release of IL-1β from peritoneal macrophages upon LPS/ATP challenge with an IC50 of 1.59 µM.
  • 体内研究:
    YQ128 (iv; 20 mg/kg) has an intermediate terminal plasma half-life (t1/2) of 6.6 hours after iv administration. YQ128 (oral; 20 mg/kg) shows delayed gastrointestinal absorption with a tmax and cmax of 12 h and 73 ng/mL, respectively. Oral bioavailability (Foral) is estimated as 10%. YQ128 exhibits extensive extravascular distribution with a large steady-state volume of distribution (Vdss) of 8.5 L/kg and rapid total clearance (CLtot) of 41 mL/min/kg. YQ128 (10 mg/kg) has been shown to trigger IL-1β production in a NLRP3- dependent manner in C57BL/6 mice. Animal Model: Sprague-Dawley rats (200-250 g) Dosage: 20 mg/kg (Pharmacokinetic Analysis) Administration: Iv Result: Had an intermediate terminal plasma half-life (t1/2) of 6.6 hours after iv administration.
  • 参考文献:
    1. Jiang Y, et al. Discovery of Second-Generation NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization. J Med Chem. 2019 Oct 31.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.834 ml 9.172 ml 18.345 ml
    5 mM 0.367 ml 1.834 ml 3.669 ml
    10 mM 0.183 ml 0.917 ml 1.834 ml
    50 mM 0.037 ml 0.183 ml 0.367 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。